Overexpression of miR-150 decreased VEGFR2 protein level in endothelial cells. by Liheng Shi (144105)

Decrease of SMAD3 protein, but not SMAD2 in DBA iPSCs. by Jingping Ge (636557)

“…The nuclear p-SMAD2 decreased in <i>RPL5</i> mutant and corrected lines. …”

No gross cardiac or renal abnormalities in WT and Pkd2+/- mice. by Ivana Y. Kuo (707543)

Nrf2 is necessary for optimal PMN migration toward CXCL12 and CXCL2 without regulating receptors expression. by Doumet Georges Helou (7255823)

Subjects:

Forced activation of STAT1 causes a significant decrease in IFN-λ expression during IAV infection. by Haitao Wei (505384)

Main components of bauxite and BCFD (wt.%). by Nian Liu (29935)

“…The desilication reaction follows a solid shrinkage core model, with a kinetic equation of 1−2/3α−(1−α)^2/3 = 15.50exp[−29299/(RT)]·t, and an apparent activation energy of 29.30 kJ/mol. …”

The lack of Nrf2 does not affect PMN phagocytic capacity. by Doumet Georges Helou (7255823)

Subjects:

Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum. by Andrew A. Jarjour (343100)

“…<i>n</i> = 3 mice per genotype. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 versus Scrib WT CL. Scale bars: A,B,D,E: 2 μm. J,K: 50 μm.</p>…”

Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines. by David Herrero Martín (286820)

“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC₅₀ concentration of fenretinide during different time points (24–48–72 hours). …”

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. by Valentin Brusseau (12769704)

Hypoxia diminishes DNMT expression and activity and increases expression and activity of TET2 and TET3. by Gregory McCarty (708081)

Subjects:

Nrf2 activation decreases PMN ROS production in response to zymosan. by Doumet Georges Helou (7255823)

Subjects:

Unilateral decrease of tracer-positive neurons after prion inoculation in the sciatic nerve. by Vladimir Ermolayev (260670)

Ectopic lesions are decreased in PUGKO mice compared to controls. by Jan Sunde (8837384)

“…PG treatment in PUGKO mice decreases the expression of FOXA2 almost 33 times compared to the non-PG TX mice. …”

Decreased recovery of NOD2^−/− compared to WT TCR transgenic CD8 T cells following respiratory influenza infection of mice. by Gloria H. Y. Lin (247710)

In-silico SHH KO results show a decrease in cytokines as comared to WT. by Shruti Marwaha (654096)

CDK16 protein level is decreased in <i>Ccnyl1</i>-/- testis. by Zhenzhen Zi (787008)

Decreased primary seed dormancy and vivipary phenotype of <i>abi4</i>. by Kai Shu (424728)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Suppression of STAT6 consistently decreases WT_III encystment. by Joshua A. Kochanowsky (7543169)